Case Page


Case Status:    ONGOING    
On or around 10/11/2017 (Ongoing date of last review)

Filing Date: March 24, 2017

According to the law firm press release, the complaint alleges that defendants caused the Company to issue false and misleading statements and/or fail to disclose, among other things, that: (1) the science behind AUGMENT had not been scientifically validated; (2) the Company was unable to achieve the purported success rates it claimed; (3) the reasons why the Company moved its studies outside of the United States; and (4) that at all relevant times, the Company's profitability and prospects were false and misleading.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States


Ticker Symbol: OVAS
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Massachusetts
DOCKET #: 17-CV-10511
JUDGE: Hon. Indira Talwani
DATE FILED: 03/24/2017
CLASS PERIOD END: 03/26/2015
  1. Lifshitz & Miller
    821 Franklin Avenue, Suite 209 , Lifshitz & Miller, NY 11530
    (516) 493-9780 (516) 280-7376 ·
  2. Matorin Law Office, LLC
    18 Grove Street, Suite 5, Matorin Law Office, LLC, MA 02482
    (781) 453-0100 ·
No Document Title Filing Date